G&A at other companies
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Clover Health Investments's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Clover Health Investments's G&A?
- Clover Health Investments (CLOV) reported G&A of $74.63M in Q1 2026.
- How has Clover Health Investments's G&A changed year-over-year?
- Clover Health Investments's G&A increased by 47.3% year-over-year, from $50.68M to $74.63M.
- What is the long-term trend for Clover Health Investments's G&A?
- Over 4 years (2021 to 2025), Clover Health Investments's G&A has grown at a 3.7% compound annual growth rate (CAGR), from $185.29M to $214.27M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.